Which has preferable valuation and earnings, ALGN or DXCM?

DexCom has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Align Technology $4.14B 2.76 $410.35M $5.75 27.76 DexCom $4.66B 7.37 $836.30M $2.53 35.99

Is ALGN or DXCM more profitable?

DexCom has a net margin of 20.12% compared to Align Technology's net margin of 9.99%. DexCom's return on equity of 35.94% beat Align Technology's return on equity. Company Net Margins Return on Equity Return on Assets Align Technology 9.99% 15.86% 10.32% DexCom 20.12% 35.94% 14.75%

Does the media favor ALGN or DXCM?

In the previous week, DexCom had 12 more articles in the media than Align Technology. MarketBeat recorded 22 mentions for DexCom and 10 mentions for Align Technology. DexCom's average media sentiment score of 1.64 beat Align Technology's score of 1.17 indicating that DexCom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 8 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 21 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media prefer HQY or ALGN?

In the previous week, HealthEquity had 4 more articles in the media than Align Technology. MarketBeat recorded 14 mentions for HealthEquity and 10 mentions for Align Technology. HealthEquity's average media sentiment score of 1.39 beat Align Technology's score of 1.17 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 11 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 8 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ALGN or HSIC?

In the previous week, Align Technology had 2 more articles in the media than Henry Schein. MarketBeat recorded 10 mentions for Align Technology and 8 mentions for Henry Schein. Align Technology's average media sentiment score of 1.17 beat Henry Schein's score of 1.00 indicating that Align Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 8 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Henry Schein 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is ALGN or MEDP more profitable?

Medpace has a net margin of 17.67% compared to Align Technology's net margin of 9.99%. Medpace's return on equity of 110.15% beat Align Technology's return on equity. Company Net Margins Return on Equity Return on Assets Align Technology 9.99% 15.86% 10.32% Medpace 17.67% 110.15% 24.84%

Does the media prefer ALGN or MEDP?

In the previous week, Medpace had 24 more articles in the media than Align Technology. MarketBeat recorded 34 mentions for Medpace and 10 mentions for Align Technology. Align Technology's average media sentiment score of 1.17 beat Medpace's score of 1.05 indicating that Align Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 8 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medpace 25 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, QTRX or ALGN?

Align Technology has higher revenue and earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Quanterix $138.90M 0.95 -$107.15M -$2.63 N/A Align Technology $4.14B 2.76 $410.35M $5.75 27.76

Does the media favor QTRX or ALGN?

In the previous week, Align Technology had 9 more articles in the media than Quanterix. MarketBeat recorded 10 mentions for Align Technology and 1 mentions for Quanterix. Align Technology's average media sentiment score of 1.17 beat Quanterix's score of -0.08 indicating that Align Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quanterix 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Align Technology 8 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Align Technology (ALGN) Competitors

$159.64 -2.91 (-1.79%)

Closing price 04:00 PM Eastern

Extended Trading

$159.81 +0.17 (+0.11%)

As of 07:04 PM Eastern

Compare

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

Should you buy Align Technology stock or one of its competitors? Align Technology's main competitors and comparable companies include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Medpace (MEDP), and Quanterix (QTRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Align Technology compare to DexCom?

Align Technology (NASDAQ:ALGN) and DexCom (NASDAQ:DXCM) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and risk.

Align Technology presently has a consensus price target of $206.36, suggesting a potential upside of 29.26%. DexCom has a consensus price target of $88.71, suggesting a potential downside of 2.58%. Given Align Technology's higher probable upside, equities research analysts plainly believe Align Technology is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67
DexCom	1 Sell rating(s)	3 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.89

Align Technology has a beta of 1.65, meaning that its stock price is 65% more volatile than the broader market. Comparatively, DexCom has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market.

DexCom has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.14B	2.76	$410.35M	$5.75	27.76
DexCom	$4.66B	7.37	$836.30M	$2.53	35.99

DexCom has a net margin of 20.12% compared to Align Technology's net margin of 9.99%. DexCom's return on equity of 35.94% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	9.99%	15.86%	10.32%
DexCom	20.12%	35.94%	14.75%

88.4% of Align Technology shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 0.8% of Align Technology shares are owned by insiders. Comparatively, 0.3% of DexCom shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, DexCom had 12 more articles in the media than Align Technology. MarketBeat recorded 22 mentions for DexCom and 10 mentions for Align Technology. DexCom's average media sentiment score of 1.64 beat Align Technology's score of 1.17 indicating that DexCom is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	8 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DexCom	21 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

DexCom beats Align Technology on 13 of the 17 factors compared between the two stocks.

How does Align Technology compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, valuation, institutional ownership and dividends.

HealthEquity has a net margin of 17.25% compared to Align Technology's net margin of 9.99%. Align Technology's return on equity of 15.86% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.25%	14.75%	9.22%
Align Technology	9.99%	15.86%	10.32%

Align Technology has higher revenue and earnings than HealthEquity. Align Technology is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.34B	6.59	$215.20M	$2.67	39.48
Align Technology	$4.14B	2.76	$410.35M	$5.75	27.76

HealthEquity currently has a consensus price target of $110.93, indicating a potential upside of 5.25%. Align Technology has a consensus price target of $206.36, indicating a potential upside of 29.26%. Given Align Technology's higher possible upside, analysts plainly believe Align Technology is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.77
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 1.6% of HealthEquity shares are held by company insiders. Comparatively, 0.8% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, HealthEquity had 4 more articles in the media than Align Technology. MarketBeat recorded 14 mentions for HealthEquity and 10 mentions for Align Technology. HealthEquity's average media sentiment score of 1.39 beat Align Technology's score of 1.17 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	11 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Align Technology	8 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has a beta of 0.21, indicating that its stock price is 79% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, indicating that its stock price is 65% more volatile than the broader market.

Summary

HealthEquity beats Align Technology on 9 of the 17 factors compared between the two stocks.

How does Align Technology compare to Henry Schein?

Align Technology (NASDAQ:ALGN) and Henry Schein (NASDAQ:HSIC) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, valuation and earnings.

88.4% of Align Technology shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 0.8% of Align Technology shares are owned by company insiders. Comparatively, 0.9% of Henry Schein shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Align Technology has a net margin of 9.99% compared to Henry Schein's net margin of 2.96%. Henry Schein's return on equity of 15.97% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	9.99%	15.86%	10.32%
Henry Schein	2.96%	15.97%	5.56%

Align Technology has higher earnings, but lower revenue than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.14B	2.76	$410.35M	$5.75	27.76
Henry Schein	$13.18B	0.76	$398M	$3.43	26.10

Align Technology has a beta of 1.65, suggesting that its share price is 65% more volatile than the broader market. Comparatively, Henry Schein has a beta of 0.8, suggesting that its share price is 20% less volatile than the broader market.

In the previous week, Align Technology had 2 more articles in the media than Henry Schein. MarketBeat recorded 10 mentions for Align Technology and 8 mentions for Henry Schein. Align Technology's average media sentiment score of 1.17 beat Henry Schein's score of 1.00 indicating that Align Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	8 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Align Technology currently has a consensus target price of $206.36, suggesting a potential upside of 29.26%. Henry Schein has a consensus target price of $92.93, suggesting a potential upside of 3.82%. Given Align Technology's stronger consensus rating and higher possible upside, equities analysts clearly believe Align Technology is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67
Henry Schein	1 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.53

Summary

Align Technology beats Henry Schein on 12 of the 17 factors compared between the two stocks.

How does Align Technology compare to Medpace?

Align Technology (NASDAQ:ALGN) and Medpace (NASDAQ:MEDP) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, institutional ownership, earnings, profitability, valuation and risk.

In the previous week, Medpace had 24 more articles in the media than Align Technology. MarketBeat recorded 34 mentions for Medpace and 10 mentions for Align Technology. Align Technology's average media sentiment score of 1.17 beat Medpace's score of 1.05 indicating that Align Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	8 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medpace	25 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Align Technology presently has a consensus price target of $206.36, suggesting a potential upside of 29.26%. Medpace has a consensus price target of $584.18, suggesting a potential downside of 5.78%. Given Align Technology's stronger consensus rating and higher possible upside, equities analysts clearly believe Align Technology is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67
Medpace	0 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.23

88.4% of Align Technology shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 0.8% of Align Technology shares are held by insiders. Comparatively, 20.5% of Medpace shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Medpace has lower revenue, but higher earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.14B	2.76	$410.35M	$5.75	27.76
Medpace	$2.53B	6.84	$451.12M	$17.06	36.34

Align Technology has a beta of 1.65, meaning that its stock price is 65% more volatile than the broader market. Comparatively, Medpace has a beta of 1.15, meaning that its stock price is 15% more volatile than the broader market.

Medpace has a net margin of 17.67% compared to Align Technology's net margin of 9.99%. Medpace's return on equity of 110.15% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	9.99%	15.86%	10.32%
Medpace	17.67%	110.15%	24.84%

Summary

Medpace beats Align Technology on 9 of the 17 factors compared between the two stocks.

How does Align Technology compare to Quanterix?

Quanterix (NASDAQ:QTRX) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

Quanterix currently has a consensus price target of $3.00, indicating a potential upside of 7.14%. Align Technology has a consensus price target of $206.36, indicating a potential upside of 29.26%. Given Align Technology's stronger consensus rating and higher probable upside, analysts plainly believe Align Technology is more favorable than Quanterix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quanterix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67

Quanterix has a beta of 1.07, meaning that its share price is 7% more volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, meaning that its share price is 65% more volatile than the broader market.

In the previous week, Align Technology had 9 more articles in the media than Quanterix. MarketBeat recorded 10 mentions for Align Technology and 1 mentions for Quanterix. Align Technology's average media sentiment score of 1.17 beat Quanterix's score of -0.08 indicating that Align Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quanterix	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Align Technology	8 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

86.5% of Quanterix shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 1.5% of Quanterix shares are held by company insiders. Comparatively, 0.8% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Align Technology has a net margin of 9.99% compared to Quanterix's net margin of -80.25%. Align Technology's return on equity of 15.86% beat Quanterix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quanterix	-80.25%	-26.09%	-19.03%
Align Technology	9.99%	15.86%	10.32%

Align Technology has higher revenue and earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quanterix	$138.90M	0.95	-$107.15M	-$2.63	N/A
Align Technology	$4.14B	2.76	$410.35M	$5.75	27.76

Summary

Align Technology beats Quanterix on 16 of the 17 factors compared between the two stocks.

Get Align Technology News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALGN vs. The Competition

Export

Metric	Align Technology	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$11.43B	$5.84B	$7.29B	$12.71B
Dividend Yield	N/A	1.75%	2.54%	10.79%
P/E Ratio	27.76	26.16	271.38	24.10
Price / Sales	2.76	69.41	638.95	90.12
Price / Cash	13.69	33.71	29.03	36.90
Price / Book	2.83	6.18	11.18	6.40
Net Income	$410.35M	$149.30M	$3.46B	$348.28M
7 Day Performance	-6.73%	0.89%	1.98%	0.91%
1 Month Performance	-4.41%	8.83%	7.32%	5.10%
1 Year Performance	6.73%	7.23%	24.76%	16.16%

Align Technology Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALGN Align Technology	4.5099 of 5 stars	$159.64 -1.8%	$206.36 +29.3%	+8.7%	$11.43B	$4.14B	27.76	20,290	Positive News
DXCM DexCom	4.3055 of 5 stars	$88.76 -1.1%	$88.71 -0.1%	+12.3%	$33.87B	$4.66B	35.08	11,000	Positive News
HQY HealthEquity	3.9973 of 5 stars	$102.33 -2.3%	$110.93 +8.4%	+17.4%	$8.76B	$1.31B	38.33	2,814	Positive News Upcoming Earnings Analyst Upgrade
HSIC Henry Schein	3.1227 of 5 stars	$89.52 -0.3%	$92.27 +3.1%	+27.2%	$10.00B	$13.18B	26.10	25,000	Analyst Upgrade
MEDP Medpace	3.5231 of 5 stars	$597.12 +3.2%	$584.18 -2.2%	+33.9%	$16.15B	$2.53B	35.00	6,200	Positive News Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALGN) was last updated on 8/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Align Technology (ALGN) Competitors

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

How does Align Technology compare to DexCom?

Summary

How does Align Technology compare to HealthEquity?

Summary

How does Align Technology compare to Henry Schein?

Summary

How does Align Technology compare to Medpace?

Summary

How does Align Technology compare to Quanterix?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALGN vs. The Competition

Align Technology Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Align Technology (ALGN) Competitors

ALGN vs. DXCM, HQY, HSIC, MEDP, and QTRX

How does Align Technology compare to DexCom?

Do analysts prefer ALGN or DXCM?

Which has more volatility and risk, ALGN or DXCM?

Which has preferable valuation and earnings, ALGN or DXCM?

Is ALGN or DXCM more profitable?

Do institutionals & insiders have more ownership in ALGN or DXCM?

Does the media favor ALGN or DXCM?

Summary

How does Align Technology compare to HealthEquity?

Is HQY or ALGN more profitable?

Which has stronger valuation & earnings, HQY or ALGN?

Do analysts prefer HQY or ALGN?

Do institutionals & insiders believe in HQY or ALGN?

Does the media prefer HQY or ALGN?

Which has more risk and volatility, HQY or ALGN?

Summary

How does Align Technology compare to Henry Schein?

Do institutionals and insiders hold more shares of ALGN or HSIC?

Is ALGN or HSIC more profitable?

Which has higher earnings & valuation, ALGN or HSIC?

Which has more risk & volatility, ALGN or HSIC?

Does the media favor ALGN or HSIC?

Do analysts prefer ALGN or HSIC?

Summary

How does Align Technology compare to Medpace?

Does the media prefer ALGN or MEDP?

Do analysts recommend ALGN or MEDP?

Do insiders and institutionals hold more shares of ALGN or MEDP?

Which has preferable valuation and earnings, ALGN or MEDP?

Which has more risk & volatility, ALGN or MEDP?

Is ALGN or MEDP more profitable?

Summary

How does Align Technology compare to Quanterix?

Do analysts prefer QTRX or ALGN?

Which has more risk & volatility, QTRX or ALGN?

Does the media favor QTRX or ALGN?

Do institutionals & insiders have more ownership in QTRX or ALGN?

Is QTRX or ALGN more profitable?

Which has better valuation and earnings, QTRX or ALGN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALGN vs. The Competition

Align Technology Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools